The Latest Breaking News from Eczema

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Bye bye inflammation, hello clean, soothed skin

They would be a lifesaver for my partner with eczema

This one makeup buy changed her look for good…

For Chris Christenberry, CEO of Rejuvaskin, skin health goes beyond skincare buzzwords and marketing trends, but is rooted in medical necessity.

Evidence suggests that early exposure to family members, food, germs, dust, dirt, pollen, and pets shapes our immune response

As the number of people with allergies grows worldwide, scientists are trying to work out precisely how and why these conditions – such as asthma and eczema – develop.

Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.

IN FULL

Researchers said the protective effect of owning a pet dog may ‘occur at a molecular level’.

Academics said that having a pet dog in early life could have a ‘protective effect’